Our singular focus is fighting humanity's worst disease, cancer.

Board of Directors

Timothy C. McQuay
Chairman of the Board

Timothy C. McQuay has served as a director of Perseon (f/k/a BSD Medical) since February 2008 and currently serves as Chairman of the Board of Directors. He is a Managing Director - Investment Banking with Noble Financial Capital Markets. Prior to joining Noble Financial Capital Markets in November 2011, Mr. McQuay was a Managing Director - Investment Banking with B Riley & Co., a Los Angeles based investment banking firm. Prior to joining B Riley in September 2008, Mr. McQuay served for ten years as Managing Director Investment Banking at A. G. Edwards & Sons, Inc., where he specialized in Healthcare, including medical technology, biotechnology and specialty pharmaceuticals. He currently serves as Chairman of the Board of Directors of Meade Instruments Corp., where he has been a director since 1997. He is also a member of the Board of Directors of Superior Industries International, Inc. Mr. McQuay holds an AB in Economics from Princeton University and an MBA from UCLA.
Timothy C. McQuay
Chairman of the Board


Timothy C. McQuay has served as a director of Perseon (f/k/a BSD Medical) since February 2008 and currently serves as Chairman of the Board of Directors. He is a Managing Director - Investment Banking with Noble Financial Capital Markets. Prior to joining Noble Financial Capital Markets in November 2011, Mr. McQuay was a Managing Director - Investment Banking with B Riley & Co., a Los Angeles based investment banking firm. Prior to joining B Riley in September 2008, Mr. McQuay served for ten ... 
Peter Vitulli
Director

Peter Vitulli has served as a director of Perseon since April 2015. Mr. Vitulli is the President and CEO of DNA Diagnostics Center (DDC). Mr. Vitulli has over 35 years of experience within the consumer products and healthcare industries in both large corporations and entrepreneurial-stage companies. Prior to joining DDC, the world’s largest provider of private DNA tests, Mr. Vitulli served as President and CEO of Sciona, Inc., a pioneering Personal Genetics company offering customized health and wellness solutions and as President and CEO for Amerifit Nutrition, Inc., a nutritional supplement company focused on women's health. Earlier in his career, Mr. Vitulli managed start-up enterprises for various investor groups and was a general manager of the $1 billion North American Gatorade business for the former Quaker Oats Company. He holds an MBA from New York University's Leonard N. Stern School of Business and a BA from College of the Holy Cross.
Peter Vitulli
Director


Peter Vitulli has served as a director of Perseon since April 2015. Mr. Vitulli is the President and CEO of DNA Diagnostics Center (DDC). Mr. Vitulli has over 35 years of experience within the consumer products and healthcare industries in both large corporations and entrepreneurial-stage companies. Prior to joining DDC, the world’s largest provider of private DNA tests, Mr. Vitulli served as President and CEO of Sciona, Inc., a pioneering Personal Genetics company offering customized health an... 
Steven G. Stewart
Director

Steven G. Stewart has served as a director of Perseon (f/k/a BSD Medical) since 2006. In December 2010, Mr. Stewart entered into an agreement to serve as the Director of Financial Affairs for Headwaters, Inc. (a New York Stock Exchange company) through 2013. From July 1998 through December 2010, he served in several management positions at Headwaters, including Director of Financial Affairs, Treasurer and as the Chief Financial Officer for approximately ten years. Prior to joining Headwaters, Mr. Stewart served as a business assurance partner for PricewaterhouseCoopers LLP (formerly Coopers & Lybrand LLP), and as an audit partner with Ernst & Young (formerly Arthur Young), including service as the Salt Lake City office Director of High Technology and Entrepreneurial Services.
Steven G. Stewart
Director


Steven G. Stewart has served as a director of Perseon (f/k/a BSD Medical) since 2006. In December 2010, Mr. Stewart entered into an agreement to serve as the Director of Financial Affairs for Headwaters, Inc. (a New York Stock Exchange company) through 2013. From July 1998 through December 2010, he served in several management positions at Headwaters, including Director of Financial Affairs, Treasurer and as the Chief Financial Officer for approximately ten years. Prior to joining Headwaters, ... 
Clint Carnell
Chief Executive Officer, President and Director

Clint Carnell brings a successful 20+year track record of building companies and creating shareholder value. He recently served as an advisor to Covidien as executive in residence. From 2011-2014 he was President, Chief Executive and Chairman of myoscience, inc., a silicon valley based medical device company specializing in using cold to treat peripheral nerve conditions in pain and aesthetics. From 2005-2011, Clint was a key member of the executive team responsible for the turnaround of Thermage, Inc. including a successful IPO and responsibility for the integration of Reliant to create Solta Medical, Inc. as Chief Operating Officer. Solta later sold to Valeant Pharmaceuticals for 280 million dollars. Clint holds a Bachelor of Arts degree from Duke University.
Clint Carnell
Chief Executive Officer, President and Director


Clint Carnell brings a successful 20+year track record of building companies and creating shareholder value. He recently served as an advisor to Covidien as executive in residence. From 2011-2014 he was President, Chief Executive and Chairman of myoscience, inc., a silicon valley based medical device company specializing in using cold to treat peripheral nerve conditions in pain and aesthetics. From 2005-2011, Clint was a key member of the executive team responsible for the turnaround of Thermag... 
Damian E. Dupuy, M.D.
Director

Damian E. Dupuy, M.D. was appointed a Director in April 2011. Dr. Dupuy has been is a Professor of Diagnostic Imaging at the Warren Alpert Medical School of Brown University since 2005, and has served as Director, Tumor Ablation, at Rhode Island Hospital in Providence, RI since 2001. Dr. Dupuy, a fellow of the American College of Radiology, is a pioneer in the growing field of image guided tumor ablation, whereby various types of thermal devices destroy tumors by direct placement through the skin under image guidance. Dr. Dupuy is internationally known for his pioneering clinical work in treating cancer patients who suffer from tumors of the lung, liver, kidney, head and neck, pelvis, adrenal and skeleton. Dr. Dupuy has led two National Cancer Institute multi-center trials and currently is the Interventional Oncology Symposium Chair of the Radiological Society of North America. Dr. Dupuy, who is a graduate of the University of Massachusetts, Amherst, and the University of Massachusetts, Medical School, has published widely on a variety of specialized medical issues and is the recipient of numerous post-graduate honors and awards, including an American College of Radiology Imaging Network Publications Merit Award in 2010.
Damian E. Dupuy, M.D.
Director


Damian E. Dupuy, M.D. was appointed a Director in April 2011. Dr. Dupuy has been is a Professor of Diagnostic Imaging at the Warren Alpert Medical School of Brown University since 2005, and has served as Director, Tumor Ablation, at Rhode Island Hospital in Providence, RI since 2001. Dr. Dupuy, a fellow of the American College of Radiology, is a pioneer in the growing field of image guided tumor ablation, whereby various types of thermal devices destroy tumors by direct placement through the s... 
Harold R. Wolcott
Director

Harold R. Wolcott has served as a director of Perseon (f/k/a BSD Medical) since April 2009. Mr. Wolcott served as President of BSD Medical from April 2009 to November 2014. Mr. Wolcott has 44 years experience managing and growing newly-formed venture capital financed corporations as well as multi-million dollar medical device businesses with international operations. He has a wide range of experience in the areas of product research, product engineering, manufacturing and plant management, as well as expertise in all aspects of sales and marketing, acquisition/integration, and the sale of medical device businesses. Prior to joining the Company, Mr. Wolcott served from August 2006 until March 2009 as President and Chief Operating Officer, and later, as Director of Dimicron Inc., a development stage medical company utilizing synthetic diamond for orthopedic applications. From March 2001 until June 2005, Mr. Wolcott served as Chief Operating Officer and Director of Rubicon Medical, Inc., a company focusing on proprietary technology in embolic protection for interventional cardiology and interventional neurology. Mr. Wolcott’s qualifications to serve on the Board include, among others, his extensive executive and operational management experience in the medical device business, his public company board experience, his knowledge of the Company, and his service as President and a director of the Company since April 2009.
Harold R. Wolcott
Director


Harold R. Wolcott has served as a director of Perseon (f/k/a BSD Medical) since April 2009. Mr. Wolcott served as President of BSD Medical from April 2009 to November 2014. Mr. Wolcott has 44 years experience managing and growing newly-formed venture capital financed corporations as well as multi-million dollar medical device businesses with international operations. He has a wide range of experience in the areas of product research, product engineering, manufacturing and plant management, as we...